“…Diltiazem is extensively metabolized in the liver into its host metabolites, primarily by deacetylation and demethylation by CYP3A4 in vitro and in vivo (Chaffman and Brogden, 1985;Pichard et al, 1990;Sutton et al, 1997;Jones et al, 1999;Nakagawa and Ishizaki, 2000;Yeo and Yeo, 2001;Kosuge et al, 2001), and probably in part by CYP2C8/9 (Sutton et al, 1997). In addition, diltiazem has been shown to increase the metabolic ratio of debrisoquine (Sakai et al, 1991), suggesting a possible interference with CYP2D6 (Molden et al, 2002). It is possible that the relevant enzyme activity to metabolize diltiazem or its metabolite(s) might be induced by themselves.…”